Allscripts Healthcare Solutions Inc

Andrew Cummings
February 17, 2017

A total of 2.35 million shares exchanged at hands and its average trading volume is standing at 2.11 million shares. Inside the closing six months period the stock's performance declined -2.36% while overall yearly performance gained 0.00%.

The company has YTD performance of 21.74 percent. (NASDAQ:MDRX) in which Cantor Fitzgerald Initiates Coverage On Allscripts Healthcare Solutions, Inc. Earnings, with 23 analysts believing the company would generate an Average Estimate of $0.15. A stock experiencing a high level of volatility has a higher ATR, and a low volatility stock has a lower ATR.

For the Current Quarter, the growth estimate for Allscripts Healthcare Solutions, 15.4%, while for the Next Quarter the stock growth estimate is 7.7%. The firm had put out a Neutral rating. (NASDAQ:MDRX) is 1.5. The Average Volume (3 months) is 2.13 Million. Tracking most recent quarter period, Price to book (P/B) ration is at 1.74 and Price to cash per share ration is at 29.91. A company with a PEG Ratio below one may be seen as undervalued while a PEG Ratio above one may signal that the company is overvalued. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell). Similarly, the company has Return on Assets of -0.2 percent, Return on Equity of -3 percent and Return on Investment of 0 Percent. J P Morgan Chase & Co reaffirmed an "overweight" rating on shares of Allscripts Healthcare Solutions in a research report on Friday, October 28th. Movements above 70 are interpreted as indicating overbought conditions; conversely moves underneath 30 notify oversold conditions. Shares are now trading -18.13% away from the 52-week high price of 15.17 and +26.73% off the 52-week low of 9.80. Investors who are keeping close eye on the stock of Allscripts Healthcare Solutions, Inc. The 1 number of analyst/s have SELL recommendation for current month on MDRX.

Allscripts reported a fourth-quarter loss of $7.4 million or $0.04 per share compared with a profit of $16.3 million or $0.09 per share a year ago. In a similar way, 3D Systems Corporation (NYSE:DDD) last announced results for quarter ended on 30 Sep 2016, disclosing EPS of $0.14.

The biggest institutional shareholders in Allscripts Healthcare Solutions, Inc. include Wellington Management Company LLP which owns 26 million shares in the company valued at $341.08 million. On average, analysts predict that Allscripts Healthcare Solutions, Inc. will post $0.57 earnings per share for the current fiscal year. These results showed an earnings surprise of 4.57% (Thomson Reuter's data). (Read Latest [Free Analytic] Facts on NASDAQ:MDRX and Be Updated) To accommodate long-term intention, the firm has diverse dividend or yield record, MDRX experts calculate Return on Investment of 1.40%.

The Stock now has Analyst' mean Recommendation of 2.1 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell. Canaccord Genuity set a $19.00 price objective on Allscripts Healthcare Solutions and gave the company a "buy" rating in a research report on Thursday, October 27th. "Outperform View" rating was issued by 4 and "Underperform Signal" rating was revealed by 1. Finally, Deutsche Bank AG cut Allscripts Healthcare Solutions from a "buy" rating to a "hold" rating and lowered their price objective for the company from $14.00 to $11.00 in a research report on Thursday, November 10th.

Other reports by iNewsToday